{
  "ptid_time": "052_S_1346_2007-10-11",
  "img_path": "/data/qiuhui/data/adni/images/052_S_1346/2007-10-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 80,641 mm³, 109.4% above the reference mean. With a Z-score of 2.62 (99.6th percentile), this represents significant enlargement; hippocampal volume measures 4,975 mm³, 34.2% below the reference mean. With a Z-score of -3.33 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,181,350 mm³, 9.4% above the reference mean. With a Z-score of 1.23 (89.0th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,246 mm³, 20.8% below the reference mean. With a Z-score of -1.41 (7.9th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,786 mm³, 0.3% below the reference mean. With a Z-score of -0.02 (49.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,654 mm³, 6.2% above the reference mean. With a Z-score of 0.55 (71.0th percentile), this represents normal volume . ",
  "text_data": "Age is 73.1 years. Gender is Male. Education: 12 years. MMSE: 28.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (Z-score 2.62) and profound hippocampal atrophy (Z-score -3.33), both strong biomarkers for Alzheimer's disease. Despite the high MMSE score (28/30), the structural changes suggest neurodegeneration, likely in the early stages given the preserved cognitive performance.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis is provisional due to the lack of clear functional decline reported)  \n\n*Note: The discrepancy between imaging (severe atrophy) and cognition (near-normal MMSE) suggests either very early disease or possible resilience factors. Follow-up cognitive testing (e.g., MoCA, episodic memory assessments) and CSF/PET biomarkers would strengthen diagnostic certainty.*",
  "timestamp": "2025-07-26T07:46:04.628697"
}